Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid

Masaya Takemura (Nagoya, Japan), Masaya Takemura, Masayuki Nishio, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Takamitsu Asano, Hisatoshi Hijikata, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Atsushi Nakamura, Kosho Yoshikawa, Akio Niimi

Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Session: Notable abstracts on clinical problems related to asthma
Session type: Poster Discussion
Number: 5016
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Masaya Takemura (Nagoya, Japan), Masaya Takemura, Masayuki Nishio, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Takamitsu Asano, Hisatoshi Hijikata, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Atsushi Nakamura, Kosho Yoshikawa, Akio Niimi. Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid. Eur Respir J 2016; 48: Suppl. 60, 5016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013



Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010


A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults
Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021
Year: 2021



Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015

The predictive value of symptoms for asthma diagnosis and inhaled steroid treatment response
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017


Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


High or standard initial dose of budesonide to control mild-to-moderate asthma?
Source: Eur Respir J 2001; 17: 856-862
Year: 2001



Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA
Source: International Congress 2014 – Paediatric asthma: what is new for the clinician?
Year: 2014